BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12403928)

  • 1. Role of CD83 in the immunomodulation of dendritic cells.
    Lechmann M; Zinser E; Golka A; Steinkasserer A
    Int Arch Allergy Immunol; 2002 Oct; 129(2):113-8. PubMed ID: 12403928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between dendritic cells and herpes simplex virus-1.
    Kobelt D; Lechmann M; Steinkasserer A
    Curr Top Microbiol Immunol; 2003; 276():145-61. PubMed ID: 12797447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD83: a regulatory molecule of the immune system with great potential for therapeutic application.
    Fujimoto Y; Tedder TF
    J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD83 on dendritic cells: more than just a marker for maturation.
    Lechmann M; Berchtold S; Hauber J; Steinkasserer A
    Trends Immunol; 2002 Jun; 23(6):273-5. PubMed ID: 12072358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
    Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
    J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound and soluble porcine CD83 functions antithetically in T cell activation and dendritic cell differentiation in vitro.
    Huo S; Zhang J; Liang S; Wu F; Zuo Y; Cui D; Zhang Y; Zhong Z; Zhong F
    Dev Comp Immunol; 2019 Oct; 99():103398. PubMed ID: 31121186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
    Lechmann M; Krooshoop DJ; Dudziak D; Kremmer E; Kuhnt C; Figdor CG; Schuler G; Steinkasserer A
    J Exp Med; 2001 Dec; 194(12):1813-21. PubMed ID: 11748282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activation of CD83-positive T cells.
    Wolenski M; Cramer SO; Ehrlich S; Steeg C; Fleischer B; von Bonin A
    Scand J Immunol; 2003 Sep; 58(3):306-11. PubMed ID: 12950676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
    Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
    J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD83 regulates lymphocyte maturation, activation and homeostasis.
    Breloer M; Fleischer B
    Trends Immunol; 2008 Apr; 29(4):186-94. PubMed ID: 18329338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity.
    Kruse M; Rosorius O; Krätzer F; Stelz G; Kuhnt C; Schuler G; Hauber J; Steinkasserer A
    J Virol; 2000 Aug; 74(15):7127-36. PubMed ID: 10888653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD83 Modulates B Cell Activation and Germinal Center Responses.
    Krzyzak L; Seitz C; Urbat A; Hutzler S; Ostalecki C; Gläsner J; Hiergeist A; Gessner A; Winkler TH; Steinkasserer A; Nitschke L
    J Immunol; 2016 May; 196(9):3581-94. PubMed ID: 26983787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.
    Hamzeh-Cognasse H; Cognasse F; Palle S; Chavarin P; Olivier T; Delézay O; Pozzetto B; Garraud O
    BMC Immunol; 2008 Sep; 9():54. PubMed ID: 18817542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
    Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M
    Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous CD83 Expression in CD4
    Liedtke K; Alter C; Günther A; Hövelmeyer N; Klopfleisch R; Naumann R; Wunderlich FT; Buer J; Westendorf AM; Hansen W
    J Immunol; 2020 Jun; 204(12):3217-3226. PubMed ID: 32341061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation.
    Prechtel AT; Turza NM; Theodoridis AA; Steinkasserer A
    J Immunol; 2007 May; 178(9):5454-64. PubMed ID: 17442926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation.
    Heilingloh CS; Kummer M; Mühl-Zürbes P; Drassner C; Daniel C; Klewer M; Steinkasserer A
    J Virol; 2015 Nov; 89(21):11046-55. PubMed ID: 26311871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function.
    Heilingloh CS; Mühl-Zürbes P; Steinkasserer A; Kummer M
    J Gen Virol; 2014 Jun; 95(Pt 6):1366-1375. PubMed ID: 24643878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity.
    Munster DJ; MacDonald KP; Kato M; Hart DJ
    Int Immunol; 2004 Jan; 16(1):33-42. PubMed ID: 14688058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
    Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DN
    Leukemia; 2016 Mar; 30(3):692-700. PubMed ID: 26286117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.